• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 传播的独特特征:与 SARS-CoV、MERS-CoV 和 2009 年 H1N1 大流行性流感病毒的比较。

The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.

机构信息

Ningxia Center for Disease Control and Prevention, Yinchuan, Ningxia, China.

College of Public Health, Ningxia Medical University, Yinchuan, Ningxia, China.

出版信息

Rev Med Virol. 2021 Mar;31(2):e2171. doi: 10.1002/rmv.2171. Epub 2020 Sep 18.

DOI:10.1002/rmv.2171
PMID:33350025
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7537046/
Abstract

From 2002 to 2019, three deadly human coronaviruses (hCoVs), severe acute respiratory syndrome coronavirus (SARS-CoV), Middle Eastern respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged to produce outbreaks of SARS, MERS and coronavirus disease 2019 (Covid-19), respectively. All three hCoVs are members of the Betacoronavirus genus in the subfamily Orthocoronavirinae and share many similarities in virology and epidemiology. However, the pattern and scale of Covid-19 global spread is similar to 2009 pandemic H1N1 influenza (H1N1pdm09), rather than SARS or MERS. Covid-19 exhibits high viral shedding in the upper respiratory tract at an early stage of infection, and has a high proportion of transmission competent individuals that are pre-symptomatic, asymptomatic and mildly symptomatic, characteristics seen in H1N1pdm09 but not in SARS or MERS. These two traits of Covid-19 and H1N1pdm09 result in reduced efficiency in identification of transmission sources by symptomatic screening and play important roles in their ability to spread unchecked to cause pandemics. To overcome these attributes of Covid-19 in community transmission, identifying the transmission source by testing for virus shedding and interrupting chains of transmission by social distancing and public masking are required.

摘要

自 2002 年至 2019 年,三种致命的人类冠状病毒(hCoVs)——严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)相继出现,分别引发了严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS)和 2019 冠状病毒病(COVID-19)疫情。这三种 hCoVs 均属于冠状病毒科β属,在病毒学和流行病学方面有许多相似之处。然而,COVID-19 在全球范围内的传播模式和规模与 2009 年大流行的 H1N1 流感(H1N1pdm09)相似,而与 SARS 或 MERS 不同。COVID-19 在感染早期在上呼吸道有很高的病毒脱落量,且具有高比例的传播能力个体,这些个体处于潜伏期、无症状和轻度症状状态,这一特征在 H1N1pdm09 中可见,但在 SARS 或 MERS 中不可见。COVID-19 和 H1N1pdm09 的这两个特征导致通过症状筛查识别传播源的效率降低,这在它们不受控制传播引发大流行的能力中发挥了重要作用。为了克服 COVID-19 在社区传播中的这些特性,需要通过检测病毒脱落来确定传播源,并通过社交距离和公众戴口罩来中断传播链。

相似文献

1
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.SARS-CoV-2 传播的独特特征:与 SARS-CoV、MERS-CoV 和 2009 年 H1N1 大流行性流感病毒的比较。
Rev Med Virol. 2021 Mar;31(2):e2171. doi: 10.1002/rmv.2171. Epub 2020 Sep 18.
2
Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.SARS-CoV-2、SARS-CoV、MERS-CoV 和甲型流感病毒的比较综述。
Front Immunol. 2020 Sep 11;11:552909. doi: 10.3389/fimmu.2020.552909. eCollection 2020.
3
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.飞沫和气溶胶传播 SARS-CoV-2 的传染性和脱落的异质性。
Elife. 2021 Apr 16;10:e65774. doi: 10.7554/eLife.65774.
4
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.从 SARS 和 MERS 到 COVID-19:三种高致病性人冠状病毒引起的严重急性呼吸道感染的简要总结和比较。
Respir Res. 2020 Aug 27;21(1):224. doi: 10.1186/s12931-020-01479-w.
5
Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?为何 COVID-19 的传播效率和攻击性比以往冠状病毒疫情中的病毒传播更高?
Biomolecules. 2020 Sep 11;10(9):1312. doi: 10.3390/biom10091312.
6
[Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].甲型H1N1流感病毒、高致病性H5N1禽流感病毒、严重急性呼吸综合征冠状病毒、中东呼吸综合征冠状病毒及2019新型冠状病毒所致病理变化与致病机制比较
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):511-516. doi: 10.3760/cma.j.cn112151-20200301-00155.
7
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.新出现的冠状病毒:首例SARS、第二例MERS和第三例SARS-CoV-2:新型冠状病毒肺炎的流行病学新进展
Infez Med. 2020 Jun 1;28(suppl 1):6-17.
8
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
9
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
10
Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.拓扑分析用于序列变异:以 54 个国家 2000 多个 COVID-19 感染 SARS-CoV-2 序列为例,与 SARS-CoV-1 和 MERS-CoV 进行比较。
Infect Genet Evol. 2021 Mar;88:104708. doi: 10.1016/j.meegid.2021.104708. Epub 2021 Jan 6.

引用本文的文献

1
The Effect of Naturally Acquired Immunity on Mortality Predictors: A Focus on Individuals with New Coronavirus.自然获得性免疫对死亡率预测指标的影响:聚焦新型冠状病毒感染者
Biomedicines. 2025 Mar 27;13(4):803. doi: 10.3390/biomedicines13040803.
2
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的免疫和炎症后果及其在肾脏疾病中的意义。
Front Immunol. 2025 Feb 12;15:1376654. doi: 10.3389/fimmu.2024.1376654. eCollection 2024.
3
The strategy to control the outbreak of an emerging respiratory infectious disease in a simulated Chinese megacity.在一个模拟的中国特大城市中控制新发呼吸道传染病爆发的策略。
Heliyon. 2024 Dec 24;11(1):e41383. doi: 10.1016/j.heliyon.2024.e41383. eCollection 2025 Jan 15.
4
Towards a Comprehensive Definition of Pandemics and Strategies for Prevention: A Historical Review and Future Perspectives.迈向大流行的全面定义及预防策略:历史回顾与未来展望
Microorganisms. 2024 Aug 30;12(9):1802. doi: 10.3390/microorganisms12091802.
5
Nanoarchitectonics for synergistic activity of multimetallic nanohybrids as a possible approach for antimicrobial resistance (AMR).用于多金属纳米杂化物协同活性的纳米构筑术作为一种对抗微生物药物耐药性(AMR)的可能方法。
J Biol Inorg Chem. 2024 Aug;29(5):477-498. doi: 10.1007/s00775-024-02066-w. Epub 2024 Jul 12.
6
Polypropylene-Rendered Antiviral by Three-Dimensionally Surface-Grafted Poly(-benzyl-4-vinylpyridinium bromide).三向表面接枝聚(-苄基-4-乙烯基吡啶溴化盐)的聚丙烯抗病毒。
ACS Appl Mater Interfaces. 2024 Feb 28;16(8):10590-10600. doi: 10.1021/acsami.3c15125. Epub 2024 Feb 11.
7
Two Receptor Binding Strategy of SARS-CoV-2 Is Mediated by Both the N-Terminal and Receptor-Binding Spike Domain.两种 SARS-CoV-2 受体结合策略均由 N 端和受体结合刺突结构域介导。
J Phys Chem B. 2024 Jan 18;128(2):451-464. doi: 10.1021/acs.jpcb.3c06258. Epub 2024 Jan 8.
8
Learning from the covid-19 outbreaks in long-term care facilities: a systematic review.从长期护理设施中的 COVID-19 疫情中学习:系统评价。
BMC Geriatr. 2023 Oct 2;23(1):618. doi: 10.1186/s12877-023-04319-w.
9
Bibliometric analysis of publication trends and topics of influenza-related encephalopathy from 2000 to 2022.2000 年至 2022 年流感相关性脑炎的发表趋势和主题的文献计量分析。
Immun Inflamm Dis. 2023 Sep;11(9):e1013. doi: 10.1002/iid3.1013.
10
A novel N95 respirator with chitosan nanoparticles: mechanical, antiviral, microbiological and cytotoxicity evaluations.一种带有壳聚糖纳米颗粒的新型N95口罩:机械性能、抗病毒性能、微生物学性能及细胞毒性评估
Discov Nano. 2023 Sep 21;18(1):118. doi: 10.1186/s11671-023-03892-8.

本文引用的文献

1
COVID-19: in the absence of vaccination - 'mask the nation'.新冠疫情:在未接种疫苗的情况下——“全民戴口罩” 。
Future Microbiol. 2020 Jul;15:963-966. doi: 10.2217/fmb-2020-0112. Epub 2020 Jul 17.
2
SARS-CoV-2 detection, viral load and infectivity over the course of an infection.在感染过程中对 SARS-CoV-2 的检测、病毒载量和传染性。
J Infect. 2020 Sep;81(3):357-371. doi: 10.1016/j.jinf.2020.06.067. Epub 2020 Jun 29.
3
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
4
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.中国 SARS-CoV-2 免疫球蛋白 M 和 G 抗体的血清流行率。
Nat Med. 2020 Aug;26(8):1193-1195. doi: 10.1038/s41591-020-0949-6. Epub 2020 Jun 5.
5
Airborne Spread of SARS-CoV-2 and a Potential Role for Air Disinfection.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的空气传播及空气消毒的潜在作用
JAMA. 2020 Jul 14;324(2):141-142. doi: 10.1001/jama.2020.7603.
6
Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China.中国武汉无症状与有症状新冠肺炎患者的临床特征比较。
JAMA Netw Open. 2020 May 1;3(5):e2010182. doi: 10.1001/jamanetworkopen.2020.10182.
7
[Epidemiological characteristics of infection in COVID-19 close contacts in Ningbo city].[宁波市新型冠状病毒肺炎密切接触者感染的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 May 10;41(5):667-671. doi: 10.3760/cma.j.cn112338-20200304-00251.
8
Viral dynamics in asymptomatic patients with COVID-19.无症状 COVID-19 患者的病毒动力学。
Int J Infect Dis. 2020 Jul;96:288-290. doi: 10.1016/j.ijid.2020.05.030. Epub 2020 May 11.
9
Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.2020 年 4 月 10 日至 11 日,加利福尼亚州洛杉矶县成年人中 SARS-CoV-2 特异性抗体的血清流行率。
JAMA. 2020 Jun 16;323(23):2425-2427. doi: 10.1001/jama.2020.8279.
10
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.新冠病毒、中东呼吸综合征病毒和严重急性呼吸综合征病毒在非人灵长类动物模型中的比较发病机制。
Science. 2020 May 29;368(6494):1012-1015. doi: 10.1126/science.abb7314. Epub 2020 Apr 17.